A Leading Location
The German capital region provides outstanding potential for development and ideal conditions for the biotechnology and pharmaceuticals industry. Its major strengths are a unique research landscape and a close network of the players along the entire value-added chain. Its many technology parks and networks in various fields of modern biotechnology provide an excellent infrastructure and form the technological backbone of the biotechnology and pharmaceuticals industry in Berlin and Brandenburg.
Are you planning on developing your company’s presence in the German capital? A good choice! We will help you implement your decision to locate or expand your company in Berlin-Brandenburg.
The ninth World Health Summit concluded in Berlin with 2,000 participants from over 80 countries and a clear call to action. Over three days, more than 250 speakers discussed the most pressing challenges in Global Health and...
Dr. Rolf Zettl joined the Berlin Institute of Health (BIH) in March 2016, having previously served as managing director of the Helmholtz Association of German Research Centres. In his new position as Chief Financial Officer, he...
Reference Number TO 32-00048
Straße des 17. Juni 135
Many Companies – One Path – Your Job
The EBiSC consortium invites you to the Workshop on "Scalability of the iPSC technology for future drug discovery & therapy" which will take place on 2-3 November 2017 at Fraunhofer-Forum in Berlin.
Regulatory issues relating to the development and clinical application of mesenchymal stem cells (MSCs)